news roundup
Novel mechanisms of action that tackle underlying disease processes is but one of the forecasts for the next five years.
| advertisment
Are Local IRBs Really Necessary?
Live Webinar: Tuesday, February 28 at 1:00pm EST
 Register now |
EU parliament says the rules for patent extension through pediatric research are not being adhered to and industry is not completing its pediatric research plans.
Schulman IRB joins two networks that support streamlining the IRB review process in multisite research, and advocating single IRB review of multisite studies.
Initially, the network, known as ERN-LUNG, will aim to create an infrastructure to promote research in the different sub-themes of rare respiratory diseases that it is focusing on.
|
|
|
| advertisment
Pediatric Oncology Trials: Changes on the Horizon
On Demand
 Learn more |
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
|
ONCOLOGY
Moffitt Cancer Center has chosen cryogenic logistics company, Cryoport to provide support for its immunology program, cancer research, therapy programs and lab moves.
Specimatch announced its web-based software service for cancer patients and oncologists, that provides clinical trials matched to a patient's genetic and clinical profiles.
The KMR Group's oncology-focused report highlights the strength of Eastern Europe, which now ranks second regionally right below Asia (excluding Japan).
Clinical trial designs haved evolved to strike a balance between having too permissive or too restrictive eligibility criteria that can impact study success and timely completion.
|
|
Articles
In order to shed light on endpoint adjudication, the LinkedIn Endpoint Adjudication Community generated an Events Charter Template to assist those in need of guidance.
The purpose of the CDISC Glossary is also to serve the community of clinical researchers by selecting and defining terms pertaining to clinical research, particularly eClinical investigations, sponsored by the pharmaceutical industry or a federal agency.
Blog Posts
While advancement in the use of standardized metrics is a plus, risk-mitigative business operational processes, and uncovering unknown risks are also important to trial execution.
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
